Country: United States
Language: English
Source: NLM (National Library of Medicine)
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E)
Actavis Pharma, Inc.
ALBUTEROL SULFATE
ALBUTEROL 0.63 mg in 3 mL
INTRABRONCHIAL
PRESCRIPTION DRUG
Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). Albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. Read this patient information completely every time your prescription is filled as information may have changed. Keep these instructions with your medication, as you may want to read them again. Albuterol sulfate inhalation solution should only be used under the direction of a physician. Your physician and pharmacist have more information about albuterol sulfate inhalation solution and the condition for which it has been prescribed. Contact them if you have additional questions. Storing your Medicine Store albuterol sulfate inhalation solution between 20° and 25° C (68° and 77° F). [See USP Controlled Room Temperature]. Vials should be protected from light before use, therefore, keep unused vials in the foil pouch. D
Albuterol sulfate inhalation solution is supplied as a 3 mL, clear, colorless, sterile, preservative-free, aqueous solution in two different strengths, 0.021% (0.63 mg) and 0.042% (1.25 mg) of albuterol (equivalent to 0.75 mg of albuterol sulfate or 1.5 mg of albuterol sulfate per 3 mL) in unit-dose low-density polyethylene (LDPE) vials. Each unit-dose LDPE vial is protected in a foil pouch, and each foil pouch contains 5 unit-dose LDPE vials. Each strength of albuterol sulfate inhalation solution is available in a shelf carton containing multiple foil pouches. Albuterol sulfate inhalation solution, 0.021% (0.63 mg/3 mL) (potency expressed as albuterol) contains 0.75 mg albuterol sulfate per 3 mL in unit-dose vials and is available in the following packaging configuration. NDC 0591-3467-53: 5 foil pouches, each containing 5 vials, total 25 vials per carton Albuterol sulfate inhalation solution, 0.042% (1.25 mg/3 mL) (potency expressed as albuterol) contains 1.50 mg albuterol sulfate per 3 mL in unit-dose vials and is available in the following packaging configuration. NDC 0591-3468-53: 5 foil pouches, each containing 5 vials, total 25 vials per carton
Abbreviated New Drug Application
ALBUTEROL SULFATE- ALBUTEROL SULFATE SOLUTION ACTAVIS PHARMA, INC. ---------- ALBUTEROL SULFATE INHALATION SOLUTION 0.042% (1.25 MG*/3 ML) AND 0.021% (0.63 MG*/3 ML) (*POTENCY EXPRESSED AS ALBUTEROL, EQUIVALENT TO 1.5 MG AND 0.75 MG ALBUTEROL SULFATE) REVISED: JANUARY 2017 RX ONLY PRESCRIBING INFORMATION DESCRIPTION Albuterol sulfate inhalation solution is a sterile, clear, colorless solution of the sulfate salt of racemic albuterol, albuterol sulfate. Albuterol sulfate is a relatively selective beta -adrenergic bronchodilator (see CLINICAL PHARMACOLOGY). The chemical name for albuterol sulfate is α [(tert- butylamino) methyl]-4-hydroxy-m-xylene-α, α'-diol sulfate (2:1) (salt), and its established chemical structure is as follows: The molecular weight of albuterol sulfate is 576.7 and the empirical formula is (C H NO ) •H SO . Albuterol sulfate is a white crystalline powder, soluble in water and slightly soluble in ethanol. The World Health Organization recommended name for albuterol is salbutamol. Albuterol sulfate inhalation solution is supplied in two strengths in unit dose vials. Each unit dose vial contains either 0.75 mg of albuterol sulfate (equivalent to 0.63 mg of albuterol) or 1.50 mg of albuterol sulfate (equivalent to 1.25 mg of albuterol) with sodium chloride and sulfuric acid in a 3-mL isotonic, sterile, aqueous solution. Sodium chloride is added to adjust isotonicity of the solution and sulfuric acid is added to adjust pH of the solution to 4.0 (see HOW SUPPLIED). Albuterol sulfate inhalation solution does not require dilution prior to administration by nebulization. For albuterol sulfate inhalation solution, like all other nebulized treatments, the amount delivered to the lungs will depend on patient factors, the jet nebulizer utilized, and compressor performance. Using the Pari LC Plus™ nebulizer (with face mask or mouthpiece) connected to a Pari PRONEB™ compressor, under _in vitro _conditions, the mean delivered dose from the mouth piece (% nominal dose) was approximately 43% of albuter Read the complete document